首页> 外文期刊>Drug Design, Development and Therapy >Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro
【24h】

Bone marrow mesenchymal stem cell-derived exosomes attenuate D-GaIN/LPS-induced hepatocyte apoptosis by activating autophagy in vitro

机译:骨髓间充质干细胞来源的外来体通过激活体外自噬减轻D-GaIN / LPS诱导的肝细胞凋亡

获取原文
       

摘要

Background: Acute liver failure is an inflammation-mediated hepatocyte injury. Mesenchymal stem cell (MSC) transplantation is currently considered to be an effective treatment strategy for acute liver failure. Exosomes are an important paracrine factor that can be used as a direct therapeutic agent. However, the use of bone marrow mesenchymal stem cell-derived exosomes (BMSC-Exos) in the treatment of acute liver failure has not been reported. Purpose: Here, we established a model of hepatocyte injury and apoptosis induced by D-galactosamine and lipopolysaccharide (D-GalN/LPS) to study the protective effect of BMSC-Exos on hepatocyte apoptosis, and further explored its protective mechanism. Methods: BMSC-Exos was identified by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA) and Western blot. Laser confocal microscopy was used to observe the uptake of Dil-Exos by hepatocytes. D-GalN/LPS-induced primary hepatocytes were pretreated with BMSC-Exos in vitro, and then the cells were harvested. The apoptosis of hepatocytes was observed by TUNEL staining, flow cytometry and Western blot. Electron microscopy and mRFP-GFP-LC3 and Western blot was used to observe autophagy. Results: BMSC-Exos increased the expression of autophagy marker proteins LC3 and Beclin-1 and promoted the formation of autophagosomes. After BMSC-Exos treatment, the expression levels of the proapoptotic proteins Bax and cleaved caspase-3 were significantly decreased, while the expression level of the anti-apoptotic protein Bcl-2 was upregulated. However, when the autophagy inhibitor 3MA was present, the effect of BMSC-Exos on inhibiting apoptosis was significantly reversed. Conclusions: Our results showed for the first time that BMSC-Exos had the potential to reduce hepatocyte apoptosis after acute liver failure. In particular, we found that BMSC-Exos attenuated hepatocyte apoptosis by promoting autophagy.
机译:背景:急性肝衰竭是炎症介导的肝细胞损伤。间充质干细胞(MSC)移植目前被认为是急性肝衰竭的有效治疗策略。外泌体是重要的旁分泌因子,可用作直接治疗剂。然而,尚未报道使用骨髓间充质干细胞来源的外来体(BMSC-Exos)治疗急性肝衰竭。目的:建立D-半乳糖胺和脂多糖(D-GalN / LPS)诱导的肝细胞损伤和凋亡模型,研究BMSC-Exos对肝细胞凋亡的保护作用,并进一步探讨其保护机制。方法:通过透射电镜(TEM),纳米颗粒跟踪分析(NTA)和蛋白质印迹法鉴定BMSC-Exos。使用激光共聚焦显微镜观察肝细胞对Dil-Exos的摄取。 D-GalN / LPS诱导的原代肝细胞在体外用BMSC-Exos预处理,然后收获细胞。 TUNEL染色,流式细胞仪和Western blot观察肝细胞凋亡。电子显微镜和mRFP-GFP-LC3和蛋白质印迹用于观察自噬。结果:BMSC-Exos增加了自噬标记蛋白LC3和Beclin-1的表达,并促进了自噬体的形成。 BMSC-Exos处理后,促凋亡蛋白Bax和裂解的caspase-3的表达水平显着降低,而抗凋亡蛋白Bcl-2的表达水平上调。但是,当存在自噬抑制剂3MA时,BMSC-Exos对细胞凋亡的抑制作用会明显逆转。结论:我们的结果首次表明,BMSC-Exos具有减少急性肝衰竭后肝细胞凋亡的潜力。特别是,我们发现BMSC-Exos通过促进自噬来减轻肝细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号